NCT06431594
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06431594
Title A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | NLD | ITA | GBR | FRA | FIN | ESP | CAN | BEL | AUS | ARG

Facility Status City State Zip Country Details
GSK Investigational Site RECRUITING Lake Mary Florida 32746 United States Details
GSK Investigational Site RECRUITING Fairway Kansas 66205 United States Details
GSK Investigational Site RECRUITING Boston Massachusetts 02114 United States Details
GSK Investigational Site RECRUITING Boston Massachusetts 02215 United States Details
GSK Investigational Site RECRUITING Detroit Michigan 48201 United States Details
GSK Investigational Site RECRUITING Grand Rapids Michigan 49546 United States Details
GSK Investigational Site RECRUITING Nashville Tennessee 37203 United States Details
GSK Investigational Site RECRUITING Dallas Texas 75230 United States Details
GSK Investigational Site RECRUITING West Valley City Utah 84119 United States Details
GSK Investigational Site RECRUITING Cipoletti Rio Negro R8324CVE Argentina Details
GSK Investigational Site RECRUITING Ciudad de Buenos Aires 1118 Argentina Details
GSK Investigational Site RECRUITING Rosario S2002 Argentina Details
GSK Investigational Site RECRUITING Blacktown New South Wales 2148 Australia Details
GSK Investigational Site RECRUITING Macquarie University New South Wales 2109 Australia Details
GSK Investigational Site RECRUITING Leuven 3000 Belgium Details
GSK Investigational Site RECRUITING Ottawa Ontario K1H 8L6 Canada Details
GSK Investigational Site RECRUITING Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site RECRUITING Montreal Quebec H2X 0A9 Canada Details
GSK Investigational Site RECRUITING Helsinki 00180 Finland Details
GSK Investigational Site RECRUITING Helsinki 00290 Finland Details
GSK Investigational Site RECRUITING Tampere 33520 Finland Details
GSK Investigational Site RECRUITING Lyon 69373 France Details
GSK Investigational Site RECRUITING Saint-Herblain 44805 France Details
GSK Investigational Site RECRUITING Villejuif 94805 France Details
GSK Investigational Site RECRUITING Roma 00168 Italy Details
GSK Investigational Site RECRUITING Rozzano MI 20089 Italy Details
GSK Investigational Site RECRUITING Saitama 350-1298 Japan Details
GSK Investigational Site RECRUITING Shizuoka 411-8777 Japan Details
GSK Investigational Site RECRUITING Tokyo 135-8550 Japan Details
GSK Investigational Site RECRUITING Amsterdam 1066 CX Netherlands Details
GSK Investigational Site RECRUITING Gyeonggi-do 10408 South Korea Details
GSK Investigational Site RECRUITING Seoul 03080 South Korea Details
GSK Investigational Site RECRUITING Seoul 03722 South Korea Details
GSK Investigational Site RECRUITING Seoul 06351 South Korea Details
GSK Investigational Site RECRUITING Barcelona 08035 Spain Details
GSK Investigational Site RECRUITING Córdoba 14004 Spain Details
GSK Investigational Site RECRUITING Girona 17007 Spain Details
GSK Investigational Site RECRUITING Madrid 28027 Spain Details
GSK Investigational Site RECRUITING Madrid 28034 Spain Details
GSK Investigational Site RECRUITING Madrid 28040 Spain Details
GSK Investigational Site RECRUITING Madrid 28046 Spain Details
GSK Investigational Site RECRUITING Pozuelo de AlarcOn Madr 28223 Spain Details
GSK Investigational Site RECRUITING Stockholm 17164 Sweden Details
GSK Investigational Site RECRUITING Uppsala SE-751 85 Sweden Details
GSK Investigational Site RECRUITING Cambridge CB2 0QQ United Kingdom Details
GSK Investigational Site RECRUITING London NW1 2PG United Kingdom Details
GSK Investigational Site RECRUITING London W1G 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field